HK11797A - Purified polylactides - Google Patents

Purified polylactides Download PDF

Info

Publication number
HK11797A
HK11797A HK11797A HK11797A HK11797A HK 11797 A HK11797 A HK 11797A HK 11797 A HK11797 A HK 11797A HK 11797 A HK11797 A HK 11797A HK 11797 A HK11797 A HK 11797A
Authority
HK
Hong Kong
Prior art keywords
polylactide
purified
drug
polylactides
colour
Prior art date
Application number
HK11797A
Other languages
English (en)
Inventor
Prikoszovich Walter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016882A external-priority patent/GB9016882D0/en
Priority claimed from GB909016840A external-priority patent/GB9016840D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK11797A publication Critical patent/HK11797A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88—Post-polymerisation treatment
    • C08G63/90—Purification; Drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08—Lactones or lactides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11797A 1990-08-01 1997-02-05 Purified polylactides HK11797A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016882A GB9016882D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds
GB909016840A GB9016840D0 (en) 1990-08-01 1990-08-01 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
HK11797A true HK11797A (en) 1997-02-14

Family

ID=26297417

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11797A HK11797A (en) 1990-08-01 1997-02-05 Purified polylactides

Country Status (27)

Country Link
EP (2) EP0816413B1 (en:Method)
JP (1) JP3137368B2 (en:Method)
KR (1) KR100255904B1 (en:Method)
AT (1) AT402503B (en:Method)
AU (1) AU650277B2 (en:Method)
CA (1) CA2048200C (en:Method)
CH (1) CH683772A5 (en:Method)
CY (1) CY1986A (en:Method)
DE (1) DE4124468B4 (en:Method)
DK (2) DK0469520T3 (en:Method)
ES (2) ES2243966T3 (en:Method)
FI (2) FI108040B (en:Method)
FR (1) FR2665453B1 (en:Method)
GB (1) GB2246573B (en:Method)
GR (1) GR3026322T3 (en:Method)
HK (1) HK11797A (en:Method)
HU (1) HUT59837A (en:Method)
IE (1) IE66185B1 (en:Method)
IL (1) IL99007A (en:Method)
IT (1) IT1252944B (en:Method)
LU (1) LU87985A1 (en:Method)
MY (1) MY108621A (en:Method)
NO (1) NO912960D0 (en:Method)
NZ (1) NZ239184A (en:Method)
PH (1) PH31047A (en:Method)
PT (1) PT98491B (en:Method)
TW (2) TW282477B (en:Method)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US5225521A (en) * 1991-12-31 1993-07-06 E. I. Du Pont De Nemours And Company Star-shaped hydroxyacid polymers
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
JPH06116381A (ja) * 1992-10-09 1994-04-26 Mitsui Toatsu Chem Inc ポリヒドロキシカルボン酸の精製方法
DE4412317A1 (de) * 1993-04-21 1994-10-27 Basf Ag Polylactid mit verbreiterter Molmassenverteilung
US5359026A (en) * 1993-07-30 1994-10-25 Cargill, Incorporated Poly(lactide) copolymer and process for manufacture thereof
US5496923A (en) * 1993-09-20 1996-03-05 Mitsui Toatsu Chemicals, Inc. Purification process of aliphatic polyester
NZ276088A (en) 1993-11-19 1999-07-29 Janssen Pharmaceutica Nv [(1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-6,7,8,9-tetrahydro-4h- pyrido[1,2-a]-pyrimidin-4-one derivatives (ie risperidone)
IL128774A (en) * 1994-03-07 2001-05-20 Dow Chemical Co Composition comprising a dendritic poymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
AU5862199A (en) 1998-09-11 2000-04-03 Michael Raschke Biologically active implants
US6362308B1 (en) * 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
WO2003006525A1 (en) * 2001-07-10 2003-01-23 Kureha Chemical Industry Company, Limited Polyhydroxycarboxylic acid and its production process
AU2002358831B2 (en) 2001-10-10 2007-09-06 Pierre Fabre Medicament Prolonged release biodegradable microspheres and method for preparing same
FR2830448B1 (fr) * 2001-10-10 2004-03-19 Pf Medicament Microspheres biodegradables a liberation prolongee et leur procede de preparation
GB0226993D0 (en) * 2002-11-19 2002-12-24 Novartis Ag Organic compounds
AU2013204972B2 (en) * 2002-11-19 2016-04-21 Novartis Ag Pharmaceutical composition comprising octreotide microparticles
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
CN101193531B (zh) 2006-11-29 2010-12-01 富准精密工业(深圳)有限公司 散热装置
WO2009091150A2 (en) * 2007-12-31 2009-07-23 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
CA2756388C (en) * 2009-03-23 2015-10-27 Micell Technologies, Inc. Biodegradable polymers with low acidic impurity
JP5594996B2 (ja) 2009-09-14 2014-09-24 三菱重工業株式会社 航空機の操縦システム
US8722845B2 (en) 2010-06-21 2014-05-13 Lg Chem, Ltd. Polylactide resin having excellent heat resistance and preparation method thereof
EP2455414A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von hochmolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren hochmolekularen resorbierbaren Polyester und deren Verwendung
EP2455415A1 (de) * 2010-11-17 2012-05-23 Evonik Röhm GmbH Verfahren zur Herstellung von niedermolekularen, resorbierbaren Polyestern, die mit dem Verfahren herstellbaren niedermolekularen resorbierbaren Polyester und deren Verwendung
CN105820332B (zh) * 2015-01-09 2018-06-29 北京化工大学 一种星形聚氨基酸和星形聚氨基酸载药纳米胶束及制备方法
EP3408305B1 (en) 2016-01-29 2024-03-06 Tolmar Inc. Purification and decolorization of polymers
CA3073842A1 (en) * 2017-08-31 2019-03-07 Evonik Corporation Improved resorbable polymer purification process
GR1009392B (el) * 2017-09-19 2018-10-25 Φαρματεν Αβεε Φαρμακευτικο σκευασμα που περιλαμβανει ενα πεπτιδικο φαρμακο και μεθοδος για την παρασκευη αυτου
GB2568526A (en) * 2017-11-20 2019-05-22 Rebio Tech Oy Composition
CN112940234B (zh) * 2021-01-28 2022-05-03 广东粤港澳大湾区黄埔材料研究院 一种高纯度聚乙丙交酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467970A (en) * 1975-05-02 1977-03-23 Ici Ltd Purification of polyethers
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
CH656884A5 (de) * 1983-08-26 1986-07-31 Sandoz Ag Polyolester, deren herstellung und verwendung.
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
US4677231A (en) * 1984-11-13 1987-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of polyether
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
JPH0610252B2 (ja) * 1985-08-21 1994-02-09 和光純薬工業株式会社 重合体の製造法
DE3641692A1 (de) * 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JP2714454B2 (ja) * 1988-11-07 1998-02-16 三井東圧化学株式会社 生体吸収性ポリエステルの製造方法
CA2040141C (en) * 1990-04-13 2002-05-14 Minoru Yamada Biodegradable high-molecular polymers, production and use therof

Also Published As

Publication number Publication date
TW218025B (en:Method) 1993-12-21
EP0469520B1 (en) 1998-02-25
FR2665453A1 (fr) 1992-02-07
DE4124468A1 (de) 1992-02-06
PT98491A (pt) 1992-06-30
FI913641A0 (fi) 1991-07-30
ATA151591A (de) 1996-10-15
CY1986A (en) 1997-09-05
JPH0641279A (ja) 1994-02-15
PT98491B (pt) 1997-12-31
CA2048200C (en) 1999-06-29
GB9116396D0 (en) 1991-09-11
ITRM910553A0 (it) 1991-07-23
EP0816413B1 (en) 2005-06-08
AU8143091A (en) 1992-02-27
AT402503B (de) 1997-06-25
NO912960D0 (no) 1991-07-30
IL99007A (en) 1994-12-29
KR920003990A (ko) 1992-03-27
MY108621A (en) 1996-10-31
PH31047A (en) 1998-02-03
ES2112259T3 (es) 1998-04-01
IT1252944B (it) 1995-07-05
JP3137368B2 (ja) 2001-02-19
IL99007A0 (en) 1992-07-15
FR2665453B1 (fr) 1995-01-27
GB2246573B (en) 1994-05-11
GB2246573A (en) 1992-02-05
AU650277B2 (en) 1994-06-16
DK0469520T3 (da) 1998-09-23
KR100255904B1 (ko) 2000-05-01
GR3026322T3 (en) 1998-06-30
TW282477B (en:Method) 1996-08-01
EP0469520A2 (en) 1992-02-05
FI913641L (fi) 1992-02-02
HUT59837A (en) 1992-07-28
FI111268B (fi) 2003-06-30
DK0816413T3 (da) 2005-08-29
NZ239184A (en) 1994-09-27
EP0469520A3 (en) 1992-10-07
EP0816413A3 (en) 1998-11-11
ES2243966T3 (es) 2005-12-01
DE4124468B4 (de) 2010-10-28
IE912697A1 (en) 1992-02-12
FI20011189L (fi) 2001-06-05
CA2048200A1 (en) 1992-02-02
IE66185B1 (en) 1995-12-13
HU912452D0 (en) 1991-12-30
EP0816413A2 (en) 1998-01-07
ITRM910553A1 (it) 1993-01-23
CH683772A5 (de) 1994-05-13
FI108040B (fi) 2001-11-15
LU87985A1 (fr) 1993-02-15

Similar Documents

Publication Publication Date Title
HK11797A (en) Purified polylactides
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
FI920664A7 (fi) Menetelmä hammas- ja sairaanhoidon alalla käytettävien restauraatioide n, proteesien tai vastaavien valmistamiseksi
EE04175B1 (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
IL94059A0 (en) Reconstituted blood cell compositions and processes for the preparation thereof
EP0589825A3 (en) Ophthalmoscope apparatus for examination and / or treatment.
EP1466606A3 (en) Use of inosine for the manufacture of a medicament for stimulating axonal outgrowth of central nervous system neurons
CA2212058A1 (en) Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
PL346904A1 (en) Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
OA09741A (en) "novel 5,11-dihydro-6H-dipzrido /3,2-b: 2',3'-e/ /1,4/ diazepin-6-ones and thiones and their use in the prevention or treatment of aids".
GB2228200B (en) Insecticide treatment and compositions therefor
EP0347864A3 (en) Anti-atherogenic agents
NO20010627D0 (no) Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose
GB8917068D0 (en) Device for extracting dental prostheses,crowns and the like
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
ZA901907B (en) Substituted(quinolin-2-yl-methoxy)phenyl-n,n'-sulphonylureas,processes for their preparation and their use in medicaments
ZA906605B (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines,and process for their preparation
EP0897988A4 (en) TKR1785'S PHYSIOLOGICALLY ACTIVE SUBSTANCES, THEIR PROCESS AND MICROBE
EP0408525A3 (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
GB8922164D0 (en) Fr 901277 substance,derivatives thereof,processes for preparation thereof and use thereof
PL301063A1 (en) Novel 5-thia-1,4-diazabicyclo[4.2.0] octane-3,8-dioxo analogs of beta-lactames, method of obtaining them and antimicrobial agent

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100730